A new report from the community-led monitoring group Ritshidze has exposed a “system-wide slide” in basic service delivery at South Africa’s public clinics. The report states this sharp decline, marked by critical staff shortages and failing patient systems, directly coincides with the drastic cuts to the US President’s Emergency Plan for Aids Relief (PEPFAR) funding. These cuts were made earlier…
Tag: HIV/AIDS
-
HIV Funding Boost Revealed by Health Minister Motsoaledi
South Africa’s vital HIV/AIDS programmes have received a crucial R2 billion lifeline from the United States Centers for Disease Control and Prevention (CDC). The HIV funding boost will be disbursed over the next six months. It will sustain existing services and prevent the collapse of critical health initiatives nationwide. Health Minister Dr Aaron Motsoaledi made the significant announcement during a…
-
Health Funding Solution: Steps by National Treasury
The National Treasury is preparing a new bill. This is a crucial move for the health sector. It will address a severe funding shortfall. The gap is a result of the withdrawal of US donor aid. This withdrawal puts essential health programs at risk. HIV/AIDS services are particularly vulnerable. The government is now proposing a health funding solution. The financial…
-
Global Fund Replenishment: Addressing Critical Needs
The fight against AIDS, TB, and malaria is at risk. Global health financing faces severe cuts. This threatens decades of progress. Urgent calls are being made for Global Fund replenishment. Without it, countless lives are in danger. Médecins Sans Frontières (MSF) has sounded an alarm. The medical group has released a new report. It is titled Deadly Gaps. The report…
-
Gilead’s Lenacapavir to Reach High-Burden Nations ‘At Cost’
The US government and Gilead Sciences have announced a landmark plan to supply the long-acting HIV prevention drug, lenacapavir, at cost to high-burden countries. This initiative aims to protect 2 million people via PEPFAR and The Global Fund. In a major step forward for global public health, the United States State Department announced a groundbreaking plan on Thursday. The aim…
-
Pharma Giants Sidelined in R15.5bn HIV Drug Tender
The National Department of Health has awarded its latest three-year antiretroviral (ARV) tender, valued at R15.5 billion. This decision leaves several of South Africa’s largest domestic pharmaceutical manufacturers without a contract. The government’s procurement strategy sidelines pharma giants and sparks a fresh debate. This debate pits aggressive cost-saving measures against its stated goal of bolstering local industrial capacity. The tender…
-
TAC Seeks to Join Legal Fray Over NHI Act
The Treatment Action Campaign (TAC), a patient advocacy organisation, seeks to join the legal battle over the future of South African healthcare. The TAC seeks to join the South African Medical Association’s (SAMA) court challenge against the National Health Insurance (NHI) Act. It states it must represent the perspective of millions who depend on the public health system. The move…
-
SA Life Expectancy Gains and Public Health Advances
South Africans are living significantly longer lives. The national life expectancy at birth has surged by an impressive 12 years since the turn of the century, according to new data. This improvement highlights major advances in public health, particularly in the fight against HIV. Furthermore, it reflects an overall enhancement of living conditions across the nation, as shown by the…
-
PEPFAR Funding Secure for Vital HIV Programmes
The United States Congress has spared the President’s Emergency Plan for AIDS Relief (PEPFAR), a cornerstone of global HIV/AIDS prevention for nearly two decades, from a potential $400 million budget cut.. The proposed reduction was part of the Trump administration’s wider “rescissions package.” This package aimed at clawing back $9.4 billion in previously approved federal spending. However, lawmakers raised significant…
-
Motsoaledi’s Budget Aims to Strengthen Health System
Health Minister Dr Aaron Motsoaledi has outlined a budget of R64.8 billion for the 2025/26 financial year. He presented a plan to Parliament aimed at strengthening the public health system. This system has been battered by years of austerity and recent geopolitical challenges. Within Motsoaledi’s budget, there are strategies in place to address infrastructure issues and healthcare staff shortages. In…
-
HIV Prevention Strategies with Lenacapavir Injection
In a decision that could fundamentally reshape the fight against HIV, the US Food and Drug Administration (FDA) has given its approval to Gilead Sciences’ lenacapavir, a groundbreaking twice-yearly injection for preventing HIV infection in adults and adolescents. Marketed under the brand name Yeztugo in the US, this innovative drug has been eagerly anticipated by both investors and HIV/AIDS activists…